Scientific Sessions

Autoimmune and rheumatic diseases in children encompass a range of conditions where the immune system mistakenly attacks healthy tissues, affecting joints, muscles, connective tissues, and sometimes internal organs. Common pediatric rheumatic disorders include juvenile idiopathic arthritis (JIA), systemic lupus erythematosus (SLE), juvenile dermatomyositis, and vasculitis. Early diagnosis is critical, as delayed treatment can result in joint damage, growth impairment, or organ complications. Advances in diagnostic tools, including autoantibody profiling, advanced imaging, and genetic testing, have enhanced the ability to detect these diseases at an early stage, enabling timely intervention and better long-term outcomes.

Recent innovations in pediatric rheumatology have transformed treatment strategies and improved quality of life for affected children. Targeted biologic therapies, immunomodulators, and precision medicine approaches allow clinicians to tailor treatment plans to individual patient needs, reducing inflammation and preventing disease progression. Multidisciplinary care—including collaboration among rheumatologists, physical therapists, occupational therapists, and psychologists—supports comprehensive management of both physical and psychosocial challenges. Additionally, patient and family education programs, telemedicine follow-ups, and digital health tools help improve adherence and empower families to manage chronic conditions effectively. By combining early diagnosis, innovative therapies, and holistic care, pediatric rheumatology continues to advance, ensuring better functional outcomes and improved well-being for children living with autoimmune and rheumatic diseases.